- Home
- SXTP vs ADTX Comparison
SXTP vs ADTX Comparison
Compare SXTP & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- ADTX
- Stock Information
- Founded
- SXTP 2010
- ADTX 2017
- Country
- SXTP United States
- ADTX United States
- Employees
- SXTP N/A
- ADTX N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- ADTX Health Care
- Exchange
- SXTP Nasdaq
- ADTX Nasdaq
- Market Cap
- SXTP 5.7M
- ADTX 4.9M
- IPO Year
- SXTP 2023
- ADTX 2020
- Fundamental
- Price
- SXTP N/A
- ADTX $0.70
- Analyst Decision
- SXTP Buy
- ADTX
- Analyst Count
- SXTP 2
- ADTX 0
- Target Price
- SXTP $3.00
- ADTX N/A
- AVG Volume (30 Days)
- SXTP 61.0K
- ADTX 359.8K
- Earning Date
- SXTP 11-13-2025
- ADTX 11-17-2025
- Dividend Yield
- SXTP N/A
- ADTX N/A
- EPS Growth
- SXTP N/A
- ADTX N/A
- EPS
- SXTP N/A
- ADTX N/A
- Revenue
- SXTP $984,494.00
- ADTX $12,051.00
- Revenue This Year
- SXTP $81.41
- ADTX $15,768.94
- Revenue Next Year
- SXTP $95.63
- ADTX N/A
- P/E Ratio
- SXTP N/A
- ADTX N/A
- Revenue Growth
- SXTP 128.70
- ADTX N/A
- 52 Week Low
- SXTP $1.22
- ADTX $0.66
- 52 Week High
- SXTP $12.45
- ADTX $464.98
- Technical
- Relative Strength Index (RSI)
- SXTP 54.01
- ADTX 28.04
- Support Level
- SXTP $1.38
- ADTX $0.67
- Resistance Level
- SXTP $1.51
- ADTX $0.77
- Average True Range (ATR)
- SXTP 0.07
- ADTX 0.07
- MACD
- SXTP 0.01
- ADTX -0.02
- Stochastic Oscillator
- SXTP 57.95
- ADTX 3.19
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.